• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Economy ‘Sweetheart’ drug deals with China are a clear and present danger to America: Sen. Hawley
Economy

‘Sweetheart’ drug deals with China are a clear and present danger to America: Sen. Hawley

by April 3, 2023
by April 3, 2023 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Critical drug shortages in the U.S. are on the rise due to a deal that gave China dominance over the global supply chain, posing a national security threat, Sen. Josh Hawley told Fox News.

Drug shortages in the U.S. increased 30% in 2022 compared to the year prior, according to a Senate Homeland Security & Governmental Affairs report released last month. Some antibiotics, anesthetics, cancer treatments, emergency room supplies and kids’ medicines are among the drugs facing shortages. 

‘We are dependent on China overwhelmingly for our critical medical supply chains,’ Hawley, who sits on the committee, said. ‘You talk about being dependent, you talk about a national security threat, that’s a national security threat.’

‘That is a direct threat to our independence and to the health of our people,’ he said.

CHINA CONTROLLING THE GLOBAL DRUG SUPPLY CHAIN THREATENS U.S. NATIONAL SECURITY: HAWLEY

In some cases, 90% of the key ingredients originate in China or India, according to the Senate report. It also found that active drug shortages peaked in the U.S. at the end of 2022. 

‘We are dependent on China overwhelmingly for our critical medical supply chains,’ Hawley said. ‘You look at the precursors, the key precursors for making pharmaceutical drugs, prescriptions that Americans rely on, 60% of those are made in China or India.’

‘We should make these drugs, including the precursors in the United States of America,’ the Missouri Republican told Fox News. ‘We can start by withdrawing China’s most favored nation status, the sweetheart trade deal that we gave them 20 years ago.’

The U.S. Senate granted China most favored nation status ahead of Beijing joining the World Trade Organization. In practice, the U.S. is obligated to provide China with preferential treatment for trade deals and tariffs. 

Hawley recently proposed a bill that would rescind China’s most favored nation trade status. The legislation would also ‘subject imports from China to higher tariff rates,’ according to his office.

‘During COVID, China threatened to withhold a key precursor drug, a key precursor element for cancer treatments,’ Sen. Hawley told Fox News. ‘If they had gone through and done that, it would have cut our supply in half at all of our [Department of Veterans Affairs] hospitals across the country overnight.’ 

Additionally, the number of FDA-approved pharmaceutical ingredient manufacturers based in China more than doubled between 2010 – 2015, according to the Senate report. 

Bringing domestic drug manufacturing back to the states is also gaining bipartisan momentum in the House of Representatives.

Two Republicans and two Democrats last month launched the Domestic Pharmaceutical Manufacturing Caucus, which is intended ‘to reduce American reliance on foreign adversaries, head off potential supply chain disruptions, and ensure a steady supply of pharmaceuticals in the event of public health emergencies or natural disasters,’ according to a press release. 

‘Currently, only about 10% of our critical prescription drugs or their precursors are made in America, 90% made somewhere else,’ Hawley told Fox News. ‘Listen, not only is that bad for patients, it’s bad for workers.’

Bringing high-paying pharmaceutical jobs back to the U.S. would help the economy while simultaneously cutting reliance on Chinese manufacturing, the senator said. But building domestic drug manufacturing facilities could take years, which, in the case of any future world conflicts, could pose a threat.

‘If we don’t do anything now, ahead of the curve, we will be at their mercy,’ he told Fox News. ‘We need to bring good-paying jobs back to this country, making these critical supplies that we literally rely on to live.’

To watch the full interview with Hawley, click here.

Jon Michael Raasch is an associate producer/writer with Fox News Digital Originals.

This post appeared first on FOX NEWS
You Might Also Like
  • Harris claims Biden fit to continue in office, despite more than 80 documented encounters in past year
  • GOP senators demand the FBI ‘repair the damage’ to it’s credibility over anti-Catholic memo debacle
  • Reported China-Cuba spy station deal shows Beijing preparing for conflict with US, House rep says
  • Democrat-led cities are already moving forward with gas stove bans that will affect millions
Share
0
FacebookTwitterPinterestWhatsapp

previous post
BEWARE Leveraged ETFs: Invest With Caution
next post
Defiant Trump announces Florida event just hours after Tuesday’s court appearance in New York

You may also like

Trump says Biden ‘will be the nominee’ amid Dem panic...

June 28, 2024

Comer raises questions about $200k ‘direct payment’ from James Biden...

October 21, 2023

The change voters seek goes beyond the left-right divide

July 24, 2024

Rep Nancy Mace says GOP ‘tone deaf’ on abortion: ‘We...

April 17, 2023

DeSantis says Trump is ‘high risk,’ ‘low reward’ GOP presidential...

November 20, 2023

Billionaire donors plan to shower Trump with millions in April:...

April 6, 2024

North Carolina state Rep. Ben Moss withdraws labor commissioner bid...

July 20, 2023

How Vice President Kamala Harris got started in politics

July 26, 2024

No handcuffs: Ex-prosecutor says Secret Service, NYPD could arrange polite...

March 21, 2023

Ohio Republican lawmakers push for revised school voucher program

June 2, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • The V Reversal is Impressive, but is it Enough?

      May 9, 2025
    • Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout, pulls outlook

      May 8, 2025
    • Don’t Buy Robinhood Stock… Until You See This Chart Setup

      May 8, 2025
    • UnitedHealthcare sued by shareholders over reaction to CEO’s killing

      May 8, 2025
    • The Unpredictable Stock Market: How to Make Sense of It

      May 8, 2025

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,633 views
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,339 views
    • 3

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 2,321 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,303 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,186 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,066)
    • Investing (538)
    • Stock (2,531)

    Popular Posts

    • 1

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 2

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 3

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • The V Reversal is Impressive, but is it Enough?

      May 9, 2025
    • Krispy Kreme stock plunges after doughnut chain pauses McDonald’s rollout,...

      May 8, 2025
    • Don’t Buy Robinhood Stock… Until You See This Chart Setup

      May 8, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,066)
    • Investing (538)
    • Stock (2,531)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Conservatives unload after Trump booked into...

    August 25, 2023

    Israeli Supreme Court hands Netanyahu a...

    January 2, 2024

    Longshot GOP candidate wants to treat...

    August 13, 2023
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here